Coloplast A/S (Coloplast A/S) Equity-to-Asset

: 0.31 (As of Dec. 2023)

View and export this data going back to 2013. Start your Free Trial

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Coloplast A/S's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $2,213 Mil. Coloplast A/S's Total Assets for the quarter that ended in Dec. 2023 was $7,109 Mil. Therefore, Coloplast A/S's Equity to Asset Ratio for the quarter that ended in Dec. 2023 was 0.31.

The historical rank and industry rank for Coloplast A/S's Equity-to-Asset or its related term are showing as below:

CLPBF' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.17 Med: 0.43 Max: 0.63
Current: 0.31

During the past 13 years, the highest Equity to Asset Ratio of Coloplast A/S was 0.63. The lowest was 0.17. And the median was 0.43.

CLPBF's Equity-to-Asset is ranked worse than
84.37% of 870 companies
in the Medical Devices & Instruments industry
Industry Median: 0.65 vs CLPBF: 0.31

Coloplast A/S Equity-to-Asset Historical Data

The historical data trend for Coloplast A/S's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Coloplast A/S Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Equity-to-Asset

Get a 7-Day Free Trial

0.54

0.55

0.52

0.22

0.36

Coloplast A/S Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Equity-to-Asset	Get a 7-Day Free Trial															0.17	0.20	0.19	0.36	0.31

Competitive Comparison

For the Medical Instruments & Supplies subindustry, Coloplast A/S's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Coloplast A/S Equity-to-Asset Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Coloplast A/S's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Coloplast A/S's Equity-to-Asset falls into.

Coloplast A/S Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Coloplast A/S's Equity to Asset Ratio for the fiscal year that ended in Sep. 2023 is calculated as

Equity to Asset (A: Sep. 2023 )	=	Total Stockholders Equity	/	Total Assets
	=	2475.636	/	6891.967
	=	0.36

Coloplast A/S's Equity to Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

Equity to Asset (Q: Dec. 2023 )	=	Total Stockholders Equity	/	Total Assets
	=	2212.94	/	7109.352
	=	0.31

Coloplast A/S (OTCPK:CLPBF) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.

Coloplast A/S Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Coloplast A/S's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Coloplast A/S (Coloplast A/S) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Coloplast A/S (OTCPK:CLPBF) » Definitions » Equity-to-Asset

Comparable Companies

Traded in Other Exchanges

CLPBY:USA COLOBc:UK 0QBO:UK COLO B:Denmark CBHD:Germany

Address

Holtedam 1-3, Humlebaek, DNK, DK-3050

Website

https://www.coloplast.com

Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy care systems, disposable containment devices, paste, powder, seals, and intermittent catheters for continence care. Coloplast also maintains a tertiary presence in the urology and woundcare markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.

Coloplast A/S (Coloplast A/S) Headlines

From GuruFocus

Coloplast A/S's Dividend Analysis

By GuruFocus Research • 12-07-2023